Table 1.
Liver |
Plasma |
|||||
---|---|---|---|---|---|---|
8OHdG (ng/g liver) |
TBARS (nmol MDA/g liver) |
Hydroperoxide (µmol DCFein/g liver) |
Bile acid (µmol/g liver) |
Triglyceride (mg/g liver) |
ALT (IU/L) |
|
Control | 4.1 ± 0.5 | 103 ± 31 | 2.29 ± 0.42 | 0.58 ± 0.35 | 20.9 ± 6.4 | 108 ± 54 |
ME3738 | 2.7 ± 0.5# | 58 ± 9# | 1.60 ± 0.10# | 0.20 ± 0.11# | 17.0 ± 4.1 | 42 ± 23# |
CA | 6.8 ± 1.5## | 295 ± 108# | 3.73 ± 0.54## | 2.92 ± 0.89## | 19.1 ± 8.8 | 266 ±89## |
CA+ME3738 | 4.1 ± 0.7** | 172 ± 28* | 2.52 ± 0.58** | 1.35 ± 0.51** | 13.2 ± 4.3 | 158 ± 52* |
Liver homogenate was prepared from Fxr-null mice fed the control, and 0.15% ME3738, 0.25% CA, or CA+ME3738 diet for 6 days. Hepatic 8OHdG concentrations were measured by ELISA. Hepatic TBARS and bile acid concentrations, and plasma ALT activity were measured by enzyme-colorimetric method. Hepatic hydroperoxide concentrations were measured as fluorescence of dichlorofluorescein-diacetate. Data are shown as mean ± S.D. (control; n=8, others; n=4).
significantly different from the control group (p<0.05, p<0.01, respectively),
significantly different from CA group (p<0.05, p<0.01, respectively)